Fig. 14From: Overexpression of TMEM79 combined with SMG5 is related to prognosis, tumor immune infiltration and drug sensitivity in hepatocellular carcinomaRole of SMG5 on immune checkpoints and drug sensitivity. A, B Correlation of SMG5 with immune checkpoints. C Correlation of expression of SMG5 with CTLA4-negative and PD1-negative efficacy. D Correlation of expression of SMG5 with CTLA4-negative and PD1-positive efficacy. E Correlation of expression of SMG5 with CTLA4-positive and PD1-negative efficacy. F Correlation of expression of SMG5 with CTLA4-positive and PD1-positive efficacyBack to article page